Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Return on Sales (2018 - 2026)

Health Catalyst filings provide 9 years of Return on Sales readings, the most recent being 0.02% for Q1 2026.

  • On a quarterly basis, Return on Sales fell 1.0% to 0.02% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.01%, a 1.0% decrease, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Sales hit 0.02% in Q1 2026 for Health Catalyst, down from 0.01% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.0% in Q2 2024 to a low of 0.02% in Q1 2026.
  • Median Return on Sales over the past 5 years was 0.0% (2023), compared with a mean of 0.0%.
  • Biggest five-year swings in Return on Sales: changed 0bps in 2022 and later decreased -1bps in 2025.
  • Health Catalyst's Return on Sales stood at 0.01% in 2022, then increased by 22bps to 0.0% in 2023, then soared by 36bps to 0.0% in 2024, then plummeted by -369bps to 0.01% in 2025, then fell by -29bps to 0.02% in 2026.
  • The last three reported values for Return on Sales were 0.02% (Q1 2026), 0.01% (Q4 2025), and 0.0% (Q3 2025) per Business Quant data.